Australian Technical Advisory Group on Immunisation (ATAGI) Statement
on the administration of seasonal influenza vaccines in 2026
ATAGI download dated 27/2/2026
Influenza virus strains included in the 2026 Southern Hemisphere seasonal influenza vaccines:
A/Missouri/11/2025 (H1N1)pdm09-like virus
A/Sydney/1359/2024 (H3N2)-like virus
B/Austria/1359417/2021 (B/Victoria lineage)-like virus
Highlights for changes to 2026 influenza vaccine formulations and dosing
The registration age for adjuvanted influenza vaccine (Fluad®) has been extended to people aged 50 years and above. Fluad is NIP funded for people aged 65 years and above. People 50 to 64 years of age can access this through the private market.
All influenza vaccines available in Australia in 2026 are trivalent (i.e. containing two A strains and one B lineage). The B Yamagata lineage virus is no longer included in influenza vaccines as it may be extinct.